AlphaCrest Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,449
| Closed | -$560K | – | 171 |
|
|
2022
Q3 | $560K | Buy |
14,449
+3,085
| +27% | +$120K | 0.03% | 931 |
|
|
2022
Q2 | $424K | Sell |
11,364
-6,838
| -38% | -$255K | 0.02% | 1006 |
|
|
2022
Q1 | $806K | Sell |
18,202
-17,325
| -49% | -$767K | 0.05% | 649 |
|
|
2021
Q4 | $1.51M | Buy |
35,527
+4,448
| +14% | +$189K | 0.06% | 592 |
|
|
2021
Q3 | $1.35M | Sell |
31,079
-34,255
| -52% | -$1.49M | 0.07% | 480 |
|
|
2021
Q2 | $2.79M | Sell |
65,334
-11,784
| -15% | -$504K | 0.12% | 240 |
|
|
2021
Q1 | $2.98M | Sell |
77,118
-24,789
| -24% | -$958K | 0.17% | 147 |
|
|
2020
Q4 | $3.66M | Buy |
101,907
+11,408
| +13% | +$410K | 0.3% | 61 |
|
|
2020
Q3 | $3.46M | Buy |
90,499
+72,869
| +413% | +$2.78M | 0.38% | 24 |
|
|
2020
Q2 | $619K | Sell |
17,630
-12,723
| -42% | -$447K | 0.1% | 305 |
|
|
2020
Q1 | $990K | Buy |
+30,353
| New | +$990K | 0.12% | 279 |
|
|
2019
Q4 | – | Sell |
-28,430
| Closed | -$1.16M | – | 1253 |
|
|
2019
Q3 | $1.16M | Buy |
+28,430
| New | +$1.16M | 0.07% | 489 |
|
|
2019
Q2 | – | Sell |
-53,972
| Closed | -$2.07M | – | 1024 |
|
|
2019
Q1 | $2.07M | Buy |
+53,972
| New | +$2.07M | 0.31% | 48 |
|